사업 내용:
Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its…
주요 정보:
본사: 영국
투자 유치:
€16M · Seed · 2026년 10월









